Sinonasal Squamous Cell Carcinoma in the Netherlands: A Population‐Based Study of 568 Cases Diagnosed in 2008–2021
Sinonasal squamous cell carcinoma is rare with approximately stable incidence rates. There is a limited, non-statistically significant, decrease in survival between 2008 and 2021. Therefore, there is a clear need for innovative treatment approaches to improve outcomes for patients with sinonasal squamous cell carcinoma.
Authors
- Caroline M. Speksnijder (ORCID: https://orcid.org/0000-0003-0540-3741)
- W. F. Julius Scheurleer (ORCID: https://orcid.org/0000-0002-6801-106X)
- Boukje A. C. van Dijk (ORCID: https://orcid.org/0000-0001-5984-4716)
- W. Weibel Braunius
- Mischa de Ridder (ORCID: https://orcid.org/0000-0002-2530-3038)
- Gerben Eise Breimer (ORCID: https://orcid.org/0000-0003-0365-3667)
- Lot A. Devriese (ORCID: https://orcid.org/0009-0009-9324-7814)
- Johannes A. Rijken (ORCID: https://orcid.org/0000-0002-4579-3249)
- Remco de Bree (ORCID: https://orcid.org/0000-0001-7128-5814)
- Lise J. van de Velde (ORCID: https://orcid.org/0009-0003-9605-1776)
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- University Medical Center Utrecht (NL)
- Netherlands Comprehensive Cancer Organisation (NL)
Publication Details
- Journal
- Head & Neck
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1002/hed.27961
- Citations
- 2
- Primary Topic
- Head and Neck Surgical Oncology
- Type
- article
- Field-Weighted Citation Impact
- 1.15